Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2026-03-02 @ 8:19 AM
Study NCT ID:
NCT00940758
Status:
COMPLETED
Last Update Posted:
2017-04-06
First Post:
2009-07-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy
Sponsor:
PharmaEngine
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Colorectal Cancer | View |
Keywords: